NYU Langone Health

118 articles about NYU Langone Health

• New Class of Compounds Found to Block Coronavirus Reproduction

  6/24/2021

  A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help it spread also makes it vulnerable to a new class of drug candidates, a new study finds.

• New Treatment Stops Progression of Alzheimer's Disease in Monkey Brains

  6/15/2021

  A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer's disease, a new study shows.

• Model Suggests Surgery Should Come Before Chemotherapy for Select Patients with Aggressive Ovarian Cancer

  6/14/2021

  Certain patients with an aggressive form of ovarian cancer have a better chance of a cure through surgical removal of their tumor before chemotherapy instead of the reverse, a new study shows.

• NYU Langone Health to Co-Lead NIH-funded Effort to Understand Long-term Effects of SARS-CoV-2 Infection

  6/10/2021

  NYU Langone Health has been selected as the Clinical Science Core for the National Institutes of Health's PASC Initiative. In this role, the CSC could potentially receive up to $52 million over the full funding period to lead and integrate the research activities of clinical sites around the country studying the long-term effects of SARS-CoV-2 infection.

• NYU Langone Health Launches At-Home Virtual Brain Stimulation Program

  5/26/2021

  tDCS Treatments Improve Symptoms Related to Conditions like Multiple Sclerosis, COVID-19 & Other Neuropsychiatric Problems

• ­Coronavirus Transmission in Queens Drove the First Wave of New York City's Pandemic

  5/20/2021

  The most populous boroughs in New York City, Queens and Brooklyn, likely served as the major hub of COVID-19 spread in the spring of 2020, a new study finds.

• ­­Breast Cancer Treatments Do Not Increase Risk of Covid-19 Infection or Death

  5/19/2021

  Cancer drugs capable of weakening the body's immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows.

• Artificial Intelligence Tool Uses Chest X-ray to Differentiate Worst Cases of COVID-19

  5/12/2021

  Trained to see patterns by analyzing thousands of chest X-rays, a computer program predicted with up to 80 percent accuracy which COVID-19 patients would develop life-threatening complications within four days, a new study finds.

• Addressing and Integrating Social Determinants of Health Effective in Reducing Blood Pressure in Patients with Hypertension or Diabetes

  4/19/2021

  While cardiovascular disease remains the leading cause of death globally, new research led by NYU Grossman School of Medicine and Moi University School of Medicine found that addressing and incorporating social determinants of health in the clinical management of blood pressure in Kenya can improve outcomes for patients with diabetes or hypertension.

• Protein Found to Control Drivers of Normal Growth and Cancer

  4/14/2021

  Researchers have found a long-sought enzyme that prevents cancer by enabling the breakdown of proteins that drive cell growth, and that causes cancer when disabled.

• Glaucoma May Be More than Just an Issue of Eye Pressure

  4/14/2021

  A chemical known to protect nerve cells also slows glaucoma, the leading cause of irreversible blindness, results of a new study in rats show.

• Cancer-Killing Virus Therapy Shows Promise Against Inoperable Skin Cancers

  4/9/2021

  Early results show that a new combination drug therapy is safe and effective against advanced skin cancer in patients who were not able to have their tumors surgically removed.

• Brain Cells Decide on Their Own When to Release Pleasure Hormone

  4/6/2021

  In addition to smoothing out wrinkles, researchers have found that the drug Botox can reveal the inner workings of the brain.

• Smile Train Appoints New Global Medical Advisory Board Member from NYU Langone

  3/16/2021

  Smile Train, the world's largest cleft organization, announced the addition of Roberto L. Flores, MD, to its Global Medical Advisory Board.

• Exposure to Flame Retardants Early in Pregnancy Linked to Premature Birth

  3/10/2021

  Expectant women are more likely to give birth early if they have high blood levels of a chemical used in flame retardants compared with those who have limited exposure, a new study finds.

• Study Maps Key Proteins Linked to Epilepsy, Revealing New Drug Targets

  3/9/2021

  An analysis of adult human brain tissue reveals over 900 proteins tied to epilepsy. The brain disorder, estimated to afflict more than 3 million Americans, is mostly known for symptoms of hallucinations, dreamlike states, and uncontrolled, often disabling bodily seizures.

• Pre-COVID Subway Air Polluted from DC to Boston, But New York Region's is the Worst, Study Finds

  2/10/2021

  Commuters now have yet another reason to avoid packing themselves into subway stations.

• NYU Langone Health Performs World's First Successful Face and Double Hand Transplant

  2/3/2021

  A surgical team from NYU Langone Health performed a face and double hand transplant for a 22-year-old New Jersey resident severely burned in a horrific car crash.